消息面上，太龙药业发布公告称，公司的控股股东将由泰容产投变更为江药控股，实际控制人将由郑州 高新技术产业开发区管理委员会变更为江西省国有资产监督管理委员会。 北京商报讯（记者 丁宁）12月9日，太龙药业（600222）开盘涨停，报涨停价9.44元/股，涨幅为 10.02%。 ...

太龙药业拟向江药控股非公开发行，拟发行数量不超过7460.52万股，发行价格为6.09元，预计募集资金 4.54亿元，募集资金主要用于补充流动资金和偿还有息负债。（数据宝） （文章来源：证券时报网） ...

Group 1 - Trump announced that Nvidia is allowed to export H200 AI chips to "approved customers" in China, with the U.S. requiring a 25% revenue share from sales, applicable to companies like AMD as well [2] - The White House economic advisor Hassett stated that Trump will announce numerous positive economic messages and advocated for continued interest rate cuts by the Federal Reserve, emphasizing that the extent of cuts should depend on data [2] - Trump plans to introduce a "One Rule" executive order to streamline regulations for AI businesses, asserting that companies should not need separate approvals from all 50 states for operations [2] Group 2 - The Dow Jones fell by 0.45%, the Nasdaq decreased by 0.14%, and the S&P 500 dropped by 0.35%, with most large tech stocks declining [3][4] - Notable declines included Tesla down over 3%, Google down over 2%, and Amazon down over 1%, while Nvidia and Microsoft saw gains of over 1% [3][4] - The Nasdaq Golden Dragon China Index rose by 0.08%, with Baidu up over 3% and Xpeng up over 2%, while Netease fell over 2% [3] Group 3 - WTI crude oil futures fell by $1.20, nearly 2%, closing at $58.88 per barrel, while Brent crude oil futures dropped by $1.26, or 1.98%, to $62.49 per barrel [5][7] - Spot gold decreased by 0.13% to $4190.48 per ounce, and spot silver fell by 0.22% to $58.13 per ounce [5][7] Group 4 - OpenAI reported a 143% increase in global paid enterprise users, with over 100,000 companies using its AI products, and employees saving 40 to 60 minutes daily using AI [11] - The technology sector saw an 11-fold increase in AI usage, with rapid growth in international markets like Germany and Japan [11] Group 5 - Paramount announced a hostile takeover bid for Warner Bros. at $30 per share, totaling $108.4 billion, following Netflix's recent agreement to acquire part of Warner's core business [12] - Trump expressed his intention to be involved in the Netflix acquisition decision, citing concerns over market share [12] Group 6 - Apple’s hardware technology senior vice president denied rumors of leaving the company, while the iPhone 17 Pro series saw a price drop, with the Pro model reduced from 8999 yuan to 8699 yuan [13]

Group 1 - TaiLong Pharmaceutical's controlling shareholder has made significant progress in planning the transfer of company shares, with an agreement reached to transfer 8.73% of the company's total shares to Jiangyao Holdings at a price of 11.043 yuan per share, totaling 553 million yuan [1] - The transfer of control to Jiangyao Holdings is expected to inject resources into TaiLong Pharmaceutical's core business, although it is subject to government approval and subsequent integration actions [1] Group 2 - Minsheng Health announced its first share buyback of 82,900 shares at a maximum price of 15.67 yuan per share, totaling 1.29 million yuan, signaling recognition of the company's value and stability in stock price [2] - If Minsheng Health increases the buyback scale, it may further boost market confidence and solidify its long-term development foundation [2] Group 3 - Gaoguang Pharmaceutical has submitted its listing application to the Hong Kong Stock Exchange, with a post-C round financing valuation exceeding 2.462 billion yuan after raising 162 million yuan [3] - The company aims to accelerate research and development with capital support, although details on its core pipeline remain undisclosed [3] Group 4 - Yuekang Pharmaceutical plans to issue shares overseas (H shares) and list on the Hong Kong Stock Exchange to enhance its comprehensive competitiveness and international brand image [4] - This move aligns with the trend of globalization for pharmaceutical companies, and attention should be paid to the timing of the issuance and market feedback [4]

e公司 . e公司，证券时报旗下专注上市公司新媒体产品，立志打造A股上市公司资讯第一平台。提供7x24小时上市公司标准化快讯，针对可能影响上市公司股价的 主题概念、行业事件及时采访二次解读，从投资者需求出发，直播上市公司有价值的活动、会议。 皮阿诺、太龙药业、ST易事特等公司或迎新实控人！ 以下文章来源于e公司 ，作者证券时报 吴志 12月8日，多家A股公司发布控制权拟变更的相关公告。 皮阿诺（002853）公告显示，公司控股股东、实际控制人马礼斌正在筹划有关公司控制权变更事宜，该事项可能导致公司实际控制人发生变更。经公司向深交所申 请，公司股票自12月9日开市起停牌，预计停牌时间不超过2个交易日。 皮阿诺未透露此次交易的更多信息，公司表示，上述事项正在筹划中，尚存在不确定性。该公司主要从事中高端定制橱柜、衣柜、门墙及其配套家居产品的研发、设 计、生产、销售、安装与售后等服务。 12月8日，皮阿诺开盘后大涨，临近尾盘时拉升涨停，收于16.24元/股，市值约30亿元。2025年三季报显示，马礼斌直接持有皮阿诺39.12%股份，为公司控股股东、实 际控制人。 太龙药业（600222）12月8日晚间披露，公司控股股 ...

皮阿诺、太龙药业、ST易事特等公司或迎新实控人！ 皮阿诺未透露此次交易的更多信息，公司表示，上述事项正在筹划中，尚存在不确定性。该公司主要从事中高端定制橱柜、衣柜、门墙及其配套家居产品 的研发、设计、生产、销售、安装与售后等服务。 12月8日，皮阿诺开盘后大涨，临近尾盘时拉升涨停，收于16.24元/股，市值约30亿元。2025年三季报显示，马礼斌直接持有皮阿诺39.12%股份，为公司 控股股东、实际控制人。 太龙药业（600222）12月8日晚间披露，公司控股股东郑州泰容产业投资有限公司（下称"泰容产投"）、持股5%以上的股东郑州众生实业集团有限公司 （以下简称"众生实业"）与江药集团江西医药控股有限公司（以下简称"江药控股"）就部分股份转让、一致行动安排、公司治理等一揽子事项达成一致， 并签署了《股份转让协议》。 协议约定，泰容产投将持有的太龙药业约8.73%股份，以11.043元/股的价格分两次转让给江药控股，总价款为5.53亿元。为实现公司控制权平稳过渡，泰 容产投还与江药控股签署了《一致行动协议》。 在此次协议转让的第一次股份交割实施完成及《一致行动协议》生效后，太龙药业的控股股东将由泰容产投变更为江 ...

如上述协议转让第一次股份交割实施完成及《一致行动协议》生效后，江药控股将持有太龙药业4230万 股股份（占公司当前总股本的7.37%），并通过一致行动安排合计控制公司14.37%的股份，公司的控股 股东将由泰容产投变更为江药控股，实际控制人将由郑州高新技术产业开发区管理委员会变更为江西省 国有资产监督管理委员会。 12月8日，太龙药业还与江药控股签署了《附条件生效的股份认购协议》，江药控股拟以现金方式全额 认购上市公司向其发行的不超过7460.52万股股票。发行完成之日（自向特定对象发行股份登记至江药 控股名下之日时），泰容产投与江药控股签订的《一致行动协议》同时终止。在不考虑其他因素导致股 本数量变动的情况下，本次协议转让及本次向特定对象发行股票完成后，按发行上限计算，江药控股将 持有太龙药业1.25亿股股份，占公司发行后总股本的19.23%。 证券时报记者赵黎昀 停牌一周后，太龙药业(600222)12月8日晚间公告，接到控股股东郑州泰容产业投资有限公司（下称"泰 容产投"）通知，其筹划的可能导致公司控制权变更的事项已与相关方达成一致并签署协议，公司股票 于12月9日（星期二）开市起复牌。 8日，泰容产投 ...

"1、不会越权干预公司经营管理活动，不会侵占公司利益； 2、自本承诺出具日至公司本次向特定对象发行股票实施完毕前，若中国证监会及上海证券交易所做出 关于填补回报措施及其承诺的其他新的监管规定的，且上述承诺不能满足中国证监会及上海证券交易所 该等规定时，本单位承诺届时将按照中国证监会及上海证券交易所的最新规定出具补充承诺； 3、切实履行公司制定的有关填补回报措施以及本单位对此作出的任何有关填补回报措施的承诺，若本 单位违反该等承诺并给公司或者投资者造成损失的，本单位愿意依法承担对公司或者投资者的补偿责 任。" 登录新浪财经APP 搜索【信披】查看更多考评等级 特此公告。 河南太龙药业股份有限公司董事会 2025年12月9日 证券代码：600222 证券简称：太龙药业 公告编号：2025-064 河南太龙药业股份有限公司 关于股东签署《股份转让协议》《一致行动协议》 及公司签署《附条件生效的股份认购协议》 暨控股股东、实际控制人拟发生变更的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 控股股东或实 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600222证券简称：太龙药业 公司声明 1、公司及董事会全体成员保证本预案内容的真实、准确、完整，并确认不存在虚假记载、误导性陈述 或重大遗漏，并对其真实性、准确性、完整性承担法律责任。 2、本预案按照《公司法》《证券法》《上市公司证券发行注册管理办法》等要求编制。 3、本次向特定对象发行A股股票完成后，公司经营与收益的变化，由公司自行负责；因本次向特定对 象发行A股股票引致的投资风险，由投资者自行负责。投资者如有任何疑问，应咨询自己的股票经纪 人、律师、专业会计师或其他专业顾问。 4、本预案是公司董事会对本次向特定对象发行A股股票的说明，任何与之相悖的声明均属不实陈述。 5、本预案所述事项并不代表审核机关对于本次向特定对象发行A股股票相关事项的实质性判断、确认 或批准。本预案所述本次向特定对象发行A股股票相关事项尚需获得公司股东会审议通过、国资主管部 门批准、通过国家市场监督管理总局反垄断审查、上海证券交易所审核通过并获得中国证券监督管理委 员会同意注册文件后方可实施。 6、本预案中如有涉及投资效益或业绩预测等内容，均不构成公司对任何投资者及相关 ...

Group 1 - Weidi Co., Ltd. plans to acquire control of Jiuxing Precision Technology, which is expected to constitute a major asset restructuring. The company will pay cash to acquire 51% of the equity from Jiangsu Zhiyue Tiancheng Enterprise Management Co., Ltd. and Jiuxing Precision Technology, aiming to gain at least 51% voting rights [2] - Purun Co., Ltd. intends to purchase 49% equity of high-performance storage company Noah Changtian through issuing shares, convertible bonds, and cash payments. Upon completion, Purun will hold 100% of Noah Changtian, which specializes in high-performance 2D NAND and derivative storage products [3] - ST Yishite is undergoing a significant share transfer, with Jiangjiang Industrial Group acquiring 4.34 billion shares, representing 18.66% of the total share capital, at a price of 5.61 yuan per share, totaling 2.437 billion yuan [5] Group 2 - Midea Group has completed its share repurchase plan, buying back 135 million shares, accounting for 1.76% of the total share capital, with a total expenditure of approximately 10 billion yuan [6] - Jingji Agricultural plans to repurchase shares using self-raised funds, with a total amount between 100 million and 200 million yuan, at a maximum price of 23.7 yuan per share [6] - Helen Zhe intends to repurchase shares with a total amount between 50 million and 100 million yuan, at a maximum price of 7.5 yuan per share [7] Group 3 - Shengda Resources plans to acquire 60% equity of Yichun Jinshi Mining for 500 million yuan, which will become a subsidiary after the transaction [7] - Guangju Energy is participating in the public transfer of an 8% stake in Shenzhen Mawan Power, aiming to increase its holding from 6.42% to 14.42% [8] - Zhongrong Marine plans to invest 2.58 billion yuan in Guangdong Yantian Port for a 20% stake through its wholly-owned subsidiary [15]